Stocks and Investing
Stocks and Investing
Wed, August 9, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Gregory Renza Reiterated (VRDN) at Buy and Held Target at $44 on, Aug 9th, 2023
Gregory Renza of RBC Capital, Reiterated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $44 on, Aug 9th, 2023.
Gregory has made no other calls on VRDN in the last 4 months.
There are 5 other peers that have a rating on VRDN. Out of the 5 peers that are also analyzing VRDN, 0 agree with Gregory's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Gregory
- Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Tuesday, July 11th, 2023
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $45 on, Tuesday, July 11th, 2023
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $47 on, Tuesday, July 11th, 2023
- Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $51 on, Wednesday, June 14th, 2023
- Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $46 on, Wednesday, June 14th, 2023
Contributing Sources